Projects per year
Fingerprint
Dive into the research topics where Marthe Verhaert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
FWOSB161: FORX - FOod interventions to Reduce immunotherapy toXicity
Verhaert, M. (Mandate) & Aspeslagh, S. (Administrative Promotor)
1/11/23 → 31/10/27
Project: Fundamental
-
Acquired hemophilia due to immune checkpoint inhibitors: a case series introducing emicizumab treatment
Wolff, L., Ertl, C., Heinzerling, L., Aspeslagh, S., Verhaert, M., Lattenist, R., Confente, C., Lambert, C. & Ilzkovitz, M., 1 Oct 2025, In: Oncologist. 30, 10, 4 p., oyaf260.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)
Mac Eochagain, C., Neuendorff, N. R., Gente, K., Leipe, J., Verhaert, M., Sam, C., de Glas, N., Kadambi, S., Canin, B., Gomes, F., Decoster, L., Korc-Grodzicki, B., Rostoft, S., Battisti, N. M. L. & Wildiers, H., 4 Feb 2025, In: Lancet Oncology. 26, 2, p. e90-e102 13 p.Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus) -
Three-year analysis of the Belgian multidisciplinary immunotoxicity (BITOX) board: organization, feasibility, and results
Verhaert, M., Aydogan, Y. & Aspeslagh, S., 28 Apr 2025, In: ESMO Real World Data and Digital Oncology. 8, p. 1-6 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Trial in Progress (TiP): The FOod intervention trial to Reduce immunotherapy toXicity (FORX)
Aspeslagh, S., Demol, J., Demuyser, T., Adriaenssens, N. & Verhaert, M., 2025. 1 p.Research output: Unpublished contribution to conference › Poster
-
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Verheijden, R. J., Burgers, F. H., Janssen, J. C., Putker, A. E., Veenstra, S. P. G. R., Hospers, G. A. P., Aarts, M. J. B., Hehenkamp, K. W., Doornebosch, V. L. E., Verhaert, M., van den Berkmortel, F. W. P. J., Chatzidionysiou, K., Llobell, A., Barros, M., Maria, A. T. J., Takeji, A., García Morillo, J.-S., Lidar, M., van Eijs, M. J. M. & Blank, C. U. & 9 others, , Aug 2024, In: European Journal of Cancer. 207, 6 p., 114172.Research output: Contribution to journal › Article › peer-review
Open AccessFile27 Citations (Scopus)22 Downloads (Pure)
Prizes
-
First price - Best oral presentation of a junior clinical abstract at BSMO
Verhaert, M. (Recipient), 1 Feb 2025
Prize: Prize (including medals and awards)
-
FWO Travel grant to SITC conference
Verhaert, M. (Recipient), Oct 2023
Prize: Prize (including medals and awards)
Activities
-
Journal club - intratumoraal microbioom
Verhaert, M. (Speaker)
24 Jan 2025Activity: Talk or presentation › Talk at a school event
-
Cardio-Oncology case
Verhaert, M. (Speaker)
6 Feb 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Three-year experience of BITOX: the Belgian multidisciplinary ImmunoTOXicity board, a nationwide initiative of the Belgian Society of Medical Oncology
Verhaert, M. (Speaker)
31 Jan 2025Activity: Talk or presentation › Talk or presentation at a conference
-
Is immunotherapy an option in patients treated with immunosuppressive medication?
Verhaert, M. (Speaker)
20 Feb 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Three-year experience of the BITOX board
Verhaert, M. (Speaker)
30 Jan 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
Press/Media
-
Podcast Host Je Levensstijl als medicijn
De Nys, L., Van der Wurff, I., Minguet, P., Pot, G., Oosterman, J., Ceulemans, M., Delaere, A., Verhaert, M., Colemont, L., D'Hooghe, M. B., Laureys, S., Fontaine, C. & Vanderlinden, J.
19/03/21 → 8/10/25
34 Media contributions
Press/Media: Public Engagement Activities
-
Delhaize Lunch & Learn: FORX-project
18/03/25
1 Media contribution
Press/Media: Public Engagement Activities
-
-
LifeMe podcast: Immuuntherapie en Darmgezondheid: Hoe Voeding de Behandeling van Kanker Beïnvloedt
9/11/24
1 Media contribution
Press/Media: Public Engagement Activities
-
Thesis
-
3-YEAR ANALYSIS OF THE BELGIAN MULTIDISCIPLINARY IMMUNOTOXICITY (BITOX) BOARD
Aydogan, Y. ((PhD) Student), Verhaert, M. (Co-promotor) & Aspeslagh, S. (Co-promotor), 10 Jun 2024Student thesis: Master's Thesis
-
Pharmacological adaptations to immunosuppressive therapy in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors
Cappelle, C. A. ((PhD) Student), Wuyts, S. (Co-promotor), Verhaert, M. (Co-promotor), Cortoos, P.-J. (Co-promotor) & Aspeslagh, S. (Promotor), 2022Student thesis: Master-after-master